Expansion of peripheral CD8+ T cells in patients with coronary artery disease: Relation to cytomegalovirus infection

Journal of Internal Medicine

Volumn 254, Issue 5, 2003, Pages 472-478

  Jonasson, L ^a   Tompa, A ^b   Wikby, A ^c  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b RYHOV COUNTY HOSPITAL   (Sweden)

^c JÖNKÖPING UNIVERSITY   (Sweden)

Author keywords

Coronary artery disease; Cytomegalovirus; Immune system; T lymphocytes

Indexed keywords

C REACTIVE PROTEIN; CD28 ANTIGEN; CD4 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR; SOLUBLE INTERLEUKIN 2 RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ANGIOCARDIOGRAPHY; ANTIGEN EXPRESSION; ARTICLE; ATHEROGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE MARKER; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOSENESCENCE; INFLAMMATION; MALE; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; THREE COLOR FLOW CYTOMETRY;

ADULT; ANTIGENS, CD28; ANTIGENS, CD57; CD8-POSITIVE T-LYMPHOCYTES; CORONARY ARTERIOSCLEROSIS; CROSS-SECTIONAL STUDIES; CYTOMEGALOVIRUS INFECTIONS; HUMANS; IMMUNITY, CELLULAR; IMMUNOPHENOTYPING; INFLAMMATION MEDIATORS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS;

EID: 0242320408     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2003.01217.x     Document Type: Article

References (43)

1. Hansson GK, Holm J, Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 1989; 135: 169-75.
2. Mazzone A, De Servi S, Vezzoli M et al. Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease. Atherosclerosis 1999; 145: 369-74.
3. Jonasson L, Linderfalk C, Olsson J, Wikby A, Olsson AG. Systemic T cell activation in stable angina pectoris. Am J Cardiol 2002; 89: 754-6.
4. Neri Serneri GG, Prisco D, Martini F et al. Acute T cell activation is detectable in unstable angina. Circulation 1997; 95: 1806-12.
5. Caligiuri G, Liuzzo G, Biasucci LM, Maseri A. Immune system activation follows inflammation in unstable angina: pathogenic inplications. J Am Coll Cardiol 1998; 32: 1295-304.
6. Biasucci LM, Vitelli A, Liuzzo G et al. Elevated levels of IL-6 in unstable angina. Circulation 1996; 94: 874-7.
7. Martens PB, Goronzy JJ, Schaid D, Weyand CM. Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. Arthritis rheum 1997; 40: 1106-14.
8. Schlesier M, Kaspar T, Gutfleisch J, Wolff-Vorbeck G, Peter HH. Activated CD4+ and CD8+ T-cell subsets in Wegener's granulomatosis. Rheumatol Int 1995; 14: 213-9.
9. Wursch AM, Gratama JW, Middeldorp JM et al. The effect of cytomegalovirus infection on T-lymphocytes after allogeneic bone marrow transplantation. Clin Exp Immunol 1985; 62: 278-87.
10. Maher P, O'Toole CM, Wreghitt TG, Spiegelhalter DJ, English TA. Cytomegalovirus infection in cardiac transplant recipients associated with chronic T cell subset ratio inversion with expansion of a Leu-7+ TS-C+ subset. Clin Exp Immunol 1985; 62: 515-24.
11. - T cells. AIDS 1994; 8: 431-41.
12. Gratama JW, Naipal AM, Oosterveer MA et al. Effects of herpes virus carrier status on peripheral T lymphocyte subsets. Blood 1987; 70: 516-23.
13. Wang ECY, Taylor-Wiedeman J, Perera P, Fisher J, Borysiewicz LK. Subsets of CD8+, CD57+ cells in normal healthy individuals: correlations with human cytomegalovirus (HCMV) carrier status, phenotypic and functional analyses. Clin Exp Immunol 1993; 94: 297-305.
14. Fish KN, Söderberg-Naucler C, Mills LK, Stenglein S, Nelson JA. Human cytomegalovirus persistently infects aortic endothelial cells. J Virol 1998; 72: 5661-8.
15. Streblow D, Söderberg-Naucler C, Vieira J et al. The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell 1999; 99: 511-20.
16. Hendrix MG, Salimans MM, van Boven CP, Bruggeman CA. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol 1990; 136: 23-8.
17. Ridker PM, Hennekens CH, Stampfer MJ, Wang F. Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation 1998; 98: 2796-9.
18. Choussat R, Montalescot G, Collet J-P et al. Effect of prior exposure to Chlamydia pneumoniae, Helicobacter pylori, or cytomeglaovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction. Am J Cardiol 2000; 86: 379-84.
19. De Backer J, Mak R, De Bacquer D et al. Parameters of inflammation and infection in a community-based case-control study of coronary heart disease. Atherosclerosis 2002; 160: 457-63.
20. Muhlestein JB, Horne BD, Carlquist JF et al. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation 2000; 102: 1917-23.
21. Zhu J, Quyyumi AA, Norman JE, Csako G, Epstein SE. Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels. J Am Coll Cardiol 1999; 34: 1738-43.
22. Blankenberg S, Rupprecht HJ, Bickel C et al. Cytomegalovirus infection with interleukin-6 response predicts cardiac mortality in patients with coronary artery disease. Gradation 2001; 103: 2915-21.
23. Ferguson FG, Wikby A, Maxson P, Olsson J, Johansson B. Immune parameters in a longitudinal study of a very old population of swedish people: a comparison between survivors and nonsurvivors. J Gerontol 1995; 50: 378-82.
24. Kettering JD, Schmidt NJ, Lenette E. Improved glycine-extracted complement-fixing antigen for human cytomagalovirus. J Clin Microbiol 1977; 6: 647-9.
25. Wikby A, Johansson B, Olsson J, Löfgren S, Nilsson B-O, Ferguson F. Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the swedish NONA study. Exp Gerontol 2002; 37: 445-53.
26. - T cell expansion - anergy or activation? Clin Exp Immunol 1996; 104: 180-4.
27. 7 Liuzzo G, Kopecky SL, Frye RL et al. Perturbation of the T cell repertoire in patients with unstable angina. Circulation 1999; 100: 2135-9.
28. Hazzan M, Labalette M, Noel C, Lelievre G, Dessaint JP. Recall response to cytomegalovirus in allograft recipients: mobilization of CD57+, CD28+ cells before expansion of CD57+, CD28-cells within the CD8+ T lymphocyte compartment. Transplantation 1997; 63: 693-8.
29. Looney RJ, Falsey A, Campbell D et al. Role of cytomegalovirus in the T cell changes seen in elderly individuals. Clin Immunol 1999; 90: 213-9.
30. Olsson J, Wikby A, Johansson B, Löfgren S, Nilsson B-O, Ferguson F. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the swedish longitudinal OCTO immune study. Mech Ageing Dev 2000; 121: 187-201.
31. Hooper M, Kallas EG, Coffin D, Campbell D, Evans TG, Looney RJ. Cytomegalovirus seropositivity is associated with the expansion of CD4+ CD28-and CD8+ CD28-T cells in rheumatoid arthritis. J Rheumtol 1999; 26: 1452-7.
32. Vaarala O, Puurunen M, Manttari M, Manninen V, Aho K, Palosuo T. Antibodies to prothrombin imply a risk of myocardial infarction in middle-aged men. Thromb Haemost 1996; 75: 456-9.
33. Wu R, Nityanand S, Berglund L, Lithell H, Holm G, Lefvert AK. Antibodies against cardiolipin and oxidatively modified LDL in 50 year-old men predict myocardial infarction. Arterioscler Thromb Vasc Biol 1997; 17: 3159-63.
34. Wu R, Lemne C, De Faire U, Frostegård J. Antibodies to platelet-activating factor are associated with borderline hypertension, early atherosclerosis and the metabolic syndrome. J Intern Med 1999; 46: 389-97.
35. Effros RB. Costimulatory mechanisms in the elderly. Vaccine 2000; 18: 1661-5.
36. Spaulding C, Guo W, Effros RB. Resistance to apoptosis in human CD8+ T cells that reach replicative senescence after multiple ronds of antigen-specific proliferation. Exp Gerontol 1999; 34: 633-44.
37. Nakajima T, Schulte S, Warrington KJ et al. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 2002; 105: 570-5.
38. Park W, Weyand CM, Schmidt D, Goronzy JJ. Co-stimulatory pathways controlling activation and peripheral tolerance of human CD4+ CD28-T cells. Eur J Immunol 1997; 27: 1082-90.
39. Bandres E, Merino J, Vazquez B et al. The increase of IFN-gamma production through aging correlates with the expanded CD8(+high)CD28(-)CD57(+) subpopulation. Clin Immunol 2000; 96: 230-5.
40. +) T cells in normal, healthy individuals specifically suppress the generation of cytotoxic T lymphocytes to Epstein-Barr virs-transformed B cell lines. Eur J Immunol 1994; 24: 2903-9.
41. Joly P, Guillon J-M, Mayaud C et al. Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes. J Immunol 1989; 143: 2193-201.
42. Autran B, Leblond V, Sadat-Sowti B et al. A soluble factor released by CD8+, CD57+ lymphocytes from bone marrow transplant patients inhibits cell-mediated cytolysis. Blood 1991; 77: 2237-41.
43. Gratama JW, Langelaar RA, Oosterveer MAP et al. Phenotypic study of CD4+ and CD8+ lymphocyte subsets in relation to cytomegalovirus carrier status and its correlate with pokeweed mitogen-induced B cell differentiation. Clin Exp Immunol 1989; 77: 245-51.